SGEN Financial Facts

Net income (loss): -15.67M
Revenue from collaboration and license agreements: 22.26M
See Full Income Statement

Accumulated other comprehensive loss: -11K
Additional paid-in capital: 960.38M
See Full Balance Sheet

Seattle Genetics Inc. (SGEN) Earnings

  |   Expand Research on SGEN
Next EPS Date 7/31/14 EPS Growth Rate -283.3%
Average EPS % Beat Rate +41.5% Revenue Growth Rate -11.6%
Average % Move 1-Wk after EPS +2.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/31/14 Q214 N/A-$0.23 N/A N/A$65.04M N/A N/A N/A
5/1/14 Q114 -$0.13-$0.21 +$0.08$68.3M$64.62M N/A Details
2/11/14 Q413 -$0.13-$0.24 +$0.11$67.4M$59.5M N/A Details
11/5/13 Q313 -$0.19-$0.22 +$0.03$57.8M$57.79M N/A Details
7/31/13 Q213 -$0.06-$0.19 +$0.13$73.6M$57.15M N/A Details
5/7/13 Q113 -$0.14-$0.20 +$0.06$57.3M$53.72M N/A Details
2/12/13 Q412 -$0.09-$0.11 +$0.02$35.35M$57.21M N/A Details
11/7/12 Q312 -$0.12-$0.15 +$0.03$49.8M$52.66M N/A Details